← back to search

Linda L. Wong

Imperial College London · US
Area of research
Hepatology · Surgery
Research interest
Research interests include Hepatocellular Carcinoma Treatment and Prognosis, Liver Disease Diagnosis and Treatment, Cholangiocarcinoma and Gallbladder Cancer Studies, and Organ Transplantation Techniques and Outcomes.
h-index
37
citations
6,219
works
265
NIH funding
primary concept
Medicine
email

Recent publications

Evaluation of kidney procurement biopsy and machine perfusion on allograft outcomes: A retrospective cohort study of the Organ Procurement and Transplantation Network database
American Journal of Transplantation 2026cited by 1position: contributordoi
Validation of 3 high-risk resectable hepatocellular carcinoma models.
2026cited by 0position: contributordoi
The impact of neoadjuvant therapy on postoperative outcomes in patients undergoing hepatectomies for hepatocellular carcinoma
HPB 2026cited by 0position: contributordoi
The Changing Pathogenesis of Liver Cancer in Hawaii over Three Decades.
2025cited by 0position: contributordoi
Predictors of Hepatic Decompensation after Yttrium90 Transarterial Radioembolization—Optimizing Patient Selection
Journal of Clinical Interventional Radiology ISVIR 2024cited by 0position: contributordoi
Disparities in Hepatocellular Carcinoma Outcomes Among Subgroups of Asians and Pacific Islanders: A SEER Database Study.
2023cited by 0position: contributordoi
Table S1 from Transcriptomics Associates Molecular Features with <sup>18</sup>F-Fluorocholine PET/CT Imaging Phenotype and Its Potential Relationship to Survival in Hepatocellular Carcinoma
2023cited by 0position: contributordoi
Table S1 from Transcriptomics Associates Molecular Features with <sup>18</sup>F-Fluorocholine PET/CT Imaging Phenotype and Its Potential Relationship to Survival in Hepatocellular Carcinoma
2023cited by 0position: contributordoi
Table S2 from Transcriptomics Associates Molecular Features with <sup>18</sup>F-Fluorocholine PET/CT Imaging Phenotype and Its Potential Relationship to Survival in Hepatocellular Carcinoma
2023cited by 0position: contributordoi
Data from Transcriptomics Associates Molecular Features with <sup>18</sup>F-Fluorocholine PET/CT Imaging Phenotype and Its Potential Relationship to Survival in Hepatocellular Carcinoma
2023cited by 0position: contributordoi
Tables S3-S8 from Transcriptomics Associates Molecular Features with <sup>18</sup>F-Fluorocholine PET/CT Imaging Phenotype and Its Potential Relationship to Survival in Hepatocellular Carcinoma
2023cited by 0position: contributordoi
Table S2 from Transcriptomics Associates Molecular Features with <sup>18</sup>F-Fluorocholine PET/CT Imaging Phenotype and Its Potential Relationship to Survival in Hepatocellular Carcinoma
2023cited by 0position: contributordoi
Supplementary Figures S2-S4 from Transcriptomics Associates Molecular Features with <sup>18</sup>F-Fluorocholine PET/CT Imaging Phenotype and Its Potential Relationship to Survival in Hepatocellular Carcinoma
2023cited by 0position: contributordoi
Tables S3-S8 from Transcriptomics Associates Molecular Features with <sup>18</sup>F-Fluorocholine PET/CT Imaging Phenotype and Its Potential Relationship to Survival in Hepatocellular Carcinoma
2023cited by 0position: contributordoi
Supplementary Figure S1 from Transcriptomics Associates Molecular Features with <sup>18</sup>F-Fluorocholine PET/CT Imaging Phenotype and Its Potential Relationship to Survival in Hepatocellular Carcinoma
2023cited by 0position: contributordoi
Supplementary Figure S1 from Transcriptomics Associates Molecular Features with <sup>18</sup>F-Fluorocholine PET/CT Imaging Phenotype and Its Potential Relationship to Survival in Hepatocellular Carcinoma
2023cited by 0position: contributordoi
Supplementary Figures S2-S4 from Transcriptomics Associates Molecular Features with <sup>18</sup>F-Fluorocholine PET/CT Imaging Phenotype and Its Potential Relationship to Survival in Hepatocellular Carcinoma
2023cited by 0position: contributordoi
Data from Transcriptomics Associates Molecular Features with <sup>18</sup>F-Fluorocholine PET/CT Imaging Phenotype and Its Potential Relationship to Survival in Hepatocellular Carcinoma
2023cited by 0position: contributordoi
Oral Cyanobacteria and Hepatocellular Carcinoma.
2022cited by 23position: contributordoi
Spontaneous Rupture of Hepatocellular Carcinoma: New Insights
Journal of Clinical and Experimental Hepatology 2022cited by 17position: contributordoi
Vasoactive Intestinal Peptide-Secreting Pheochromocytoma: A Case Report and Review of Literature
AACE Clinical Case Reports 2022cited by 3position: contributordoi
β2-spectrin (SPTBN1) as a therapeutic target for diet-induced liver disease and preventing cancer development.
2021cited by 37position: contributordoi
Genetic susceptibility to hepatocellular carcinoma in chromosome 22q13.31, findings of a genome-wide association study.
2021cited by 16position: contributordoi
The Impact of Liver Transplantation on Hepatocellular Carcinoma Mortality in the United States.
2021cited by 6position: contributordoi
Can the Timed Up & Go Test and Montreal Cognitive Assessment predict outcomes in patients waitlisted for renal transplant?
2021cited by 5position: contributordoi
Serum metabolite profiles are associated with the presence of advanced liver fibrosis in Chinese patients with chronic hepatitis B viral infection
BMC Medicine 2020cited by 51position: middledoi
Transcriptomics Associates Molecular Features with <sup>18</sup>F-Fluorocholine PET/CT Imaging Phenotype and Its Potential Relationship to Survival in Hepatocellular Carcinoma.
2019cited by 11position: contributordoi
Should a homeless person become a deceased organ donor?
2019cited by 3position: contributordoi
miR-192-5p Silencing by Genetic Aberrations Is a Key Event in Hepatocellular Carcinomas with Cancer Stem Cell Features
Cancer Research 2018cited by 97position: middledoi
Association of Non-alcoholic Fatty Liver Disease with Chronic Kidney Disease: A Systematic Review and Meta-analysis
PLoS Medicine 2014cited by 718position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

· 26 papers (2019–2026)Sandi A. Kwee · University of Hawaiʻi at Mānoa14 papers (2019–2025) · 14 papers (2019–2025)Runmin Wei · The University of Texas MD Anderson Cancer Center13 papers (2019–2023)Maarit Tiirikainen · UCSF Helen Diller Family Comprehensive Cancer Center13 papers (2019–2023)Herbert Yu · Chongqing Three Gorges University3 papers (2021–2022)Lopa Mishra · Donald & Barbara Zucker School of Medicine at Hofstra/Northwell2 papers (2021–2021)Brenda Y. Hernandez · Pacific University2 papers (2018–2025)Hua Bian · Sun Yat-sen University1 papers (2020–2020)Yuanzhuo Gu · Zhejiang University1 papers (2018–2018)Hongjun Gao · Anhui Medical University1 papers (2018–2018) · 1 papers (2020–2020)Niya Liu · Shaoxing University1 papers (2018–2018)Xiaoning Wang · Binzhou Medical University1 papers (2020–2020)Xin Gao · Inner Mongolia University1 papers (2020–2020)Wei Jia · Nanjing University of Aeronautics and Astronautics1 papers (2020–2020)Hua Zhang · Jiangxi University of Traditional Chinese Medicine1 papers (2020–2020)Ping Liu · Jinan Maternity And Care Hospital1 papers (2020–2020)Qi-Min Zhan · Ministry of Education1 papers (2018–2018)Xin Zheng · Chongqing Normal University1 papers (2018–2018)